Clinical Trial Update: A Study of LY4006895 in Healthy Participants With Early Symptomatic Alzheimer's Disease (AD) [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating LY4006895 in healthy participants with early symptomatic Alzheimer's disease; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• LY4006895 (LY4006895)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Alzheimer Disease, Healthy | Phase 1 | Status: RECRUITING